Back

Lifetime risk of cardiomyopathy in the general population: a nationwide cohort study from Sweden

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in myocardial disease Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Erik Linner

Skane University Hospital, Lund (Sweden)

6 More presentations in this session

Presentation thumbnail
A novel prediction model for heart failure-related death in hypertrophic cardiomyopathy
Doctor Y. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Phenotype- and genotype-specific dominance of arrhythmic versus heart failure trajectories in inherited cardiomyopathies
Assistant Professor A. Antonopoulos (Athens, GR)
Abstract
Presentation thumbnail
Unmasking risk in asymptomatic hypertrophic cardiomyopathy: clinical and multimodality imaging determinants of disease progression and adverse outcomes
Doctor S. Keen (Cleveland, US)
Abstract
Presentation thumbnail
Genetic test yield in non-dilated left ventricular cardiomyopathy
Doctor A. Faggiano (Milan, IT)
Abstract
Presentation thumbnail
Machine-learning clustering uncovers divergent response pathways to mavacamten in obstructive HCM: a portuguese multicentre perspective
Doctor I. Miranda (Amadora, PT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in myocardial disease

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Incidence and mortality of women diagnosed with peripartum cardiomyopathy from 1997 to 2019 in Sweden, national registry-based study.
29 August 2022
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies
11 May 2024
thumbnail
Congress Presentation
Prediction of lifetime cardiovascular risk and individual lifetime treatment benefit in four European risk regions: geographic recalibration of the LIFE-CVD model
28 August 2022
thumbnail
Congress Presentation
Atrial fibrillation and stroke risk of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: a nationwide cohort study.
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources